Genome Sequencing
How an enhanced whole genome sequencing test helped identify genetic markers predicting piromelatine treatment response in patients with mild Alzheimer’s disease
In a study published in The Journal of Prevention of Alzheimer’s Disease (JPAD) – and co-authored by the Department of Psychiatry and the Behavioral Sciences, and Department of Neurology, Keck
